The commercialization of molecular biology: Walter Gilbert and the Biogen startup

References

• Adams, Daniel D. “Oral History.” Life Sciences Foundation, 2011.
   Google Scholar
• Alafi, Moshe. “Oral History.” Biogen, Inc., 2000.
   Google Scholar
• Biogen S. A. “Memorandum of Private Placement” (May 19, 1978).
   Google Scholar
• Cawthorn, Rob. “Oral History.” Biogen, Inc., 2001.
   Google Scholar
• D’Andrade, Hugh. “Oral history.” Chemical Heritage Foundation, 1998.
   Google Scholar
• Donis-Keller, Helen. “Oral History.” Life Sciences Foundation, 2013.
   Google Scholar
• Flavell, Richard. “Oral History.” Life Sciences Foundation, 2013.
   Google Scholar
• Flavell, Richard. “Oral History.” Biogen, Inc., 2000.
   Google Scholar
• Gelfand, David. “Oral History.” Life Sciences Foundation, 2012.
   Google Scholar
• Gilbert, Walter. “Oral History.” Biogen, Inc., 2000.
   Google Scholar
• Gilbert, Walter. “Oral History.” Life Sciences Foundation, 2013.
   Google Scholar
• Hartley, Brian. “Oral History.” Biogen, Inc., 2000.
   Google Scholar
• Haseltine, William. “Oral History.” Life Sciences Foundation, 2012.
   Google Scholar
• Hofschneider, Peter-Hans. “Oral History.” Biogen, Inc., 2000.
   Google Scholar
• Kamen, Robert. “Oral History.” Life Sciences Foundation, 2014.
   Google Scholar
• Mach, Bernard. “Oral History.” Biogen, Inc., 2000.
   Google Scholar
• Murray, Kenneth. “Oral History.” Biogen, Inc., 2000.
   Google Scholar
• Rosen, Joe. “Oral History.” Biogen, Inc., 2000.
   Google Scholar
• Schaller, Heinz. “Oral History.” Biogen, Inc., 2003.
   Google Scholar
• Sharp, Phillip A. “Oral History.” Chemical Heritage Foundation, 2003.
   Google Scholar
• Sharp, Philip A. “Oral History.” Life Sciences Foundation, 2012.
   Google Scholar
• Sharp, Phillip A. “Oral History.” Biogen, Inc., 2000.
   Google Scholar
• Skaletsky, Mark. “Oral History.” Life Sciences Foundation, 2013.
   Google Scholar
• Taunton-Rigby, Alison. “Oral History.” Life Sciences Foundation, 2013.
   Google Scholar
• Vincent, Jim. “Oral History.” Life Sciences Foundation, 2013.
   Google Scholar
• Vincent, Jim. “Oral History.” Biogen, Inc., 2000.
   Google Scholar
• Weissmann, Charles. “Oral History.” Biogen, Inc., 2000.
   Google Scholar
• Weissmann, Charles. “Oral History.” Life Sciences Foundation, 2012.
   Google Scholar

• Abir-Am, Pnina. “Molecular Biology in the Context of British, French, and American Cultures.” International Social Science Journal 53 (2001): 187–199.10.1111/issj.2001.53.issue-168
   Google Scholar
• Abir-Am, Pnina. “The Politics of Macromolecules: Molecular Biologists, Biochemists, and Rhetoric.” Osiris 7 (1992): 164–191.10.1086/368709
   PubMed Web of Science ®Google Scholar
• Abir-Am, Pnina. “The Rockefeller Foundation and the Rise of Molecular Biology.” Molecular Cell Biology 3 (2002): 63–70.
   Google Scholar
• Alafi, Moshe. “Biotech Pioneer and Entrepreneur.” Oral history conducted by Sally Smith Hughes. Berkeley: University of California, 2013.
   Google Scholar
• Allen, Ernest M. “Early Years of NIH Research Grants.” NIH Alumni Association Newsletter 2 (April 1980): 6–8.
   Google Scholar
• Appel, Toby A., and Shaping Biology. The National Science Foundation and American Biological Research, 1945–1975. Baltimore, MD: Johns Hopkins University Press, 2000.
   Google Scholar
• Bauer, Nancy F. “The Ptashne Fiasco.” The Harvard Crimson (June 4, 1981).
   Google Scholar
• Beer, John J., and W. David Lewis. “Aspects of the Professionalization of Science.” Daedalus 92 (Fall 1963): 764–784.
   Web of Science ®Google Scholar
• Ben-David, Joseph. “The Universities and the Growth of Science in Germany and the United States.” Minerva 7 (Autumn–Winter 1968–1969): 1–35.10.1007/BF01096806
   Web of Science ®Google Scholar
• Berg, Paul, and Janet E. Mertz. “Personal Reflections on the Origins and Emergence of Recombinant DNA Technology.” Genetics 184 (2010): 9–17.10.1534/genetics.109.112144
   PubMed Web of Science ®Google Scholar
• Berman, Elizabeth Popp. Creating the Market University: How Academic Science Became an Economic Engine. Princeton, NJ: Princeton University Press, 2011.
   Google Scholar
• Bloom, Floyd E., and Mark A. Randolph, eds. Funding Health Sciences Research: A Strategy for Restoring Balance. Washington, DC: National Academies Press, 1990.
   Google Scholar
• Bok, Derek. Beyond the Ivory Tower: Social Responsibilities of the Modern University. Cambridge, MA: Harvard University Press, 1982.
   Google Scholar
• Bourne, Henry R. Paths to Innovation: Discovering Recombinant DNA, Oncogenes, and Prions in One Medical School, Over One Decade. Berkeley: University of California Press, 2011.
   Google Scholar
• Boyer, Herbert. “Recombinant DNA Research at UCSF and Its Commercialization at Genentech.” Oral history conducted by Sally Smith Hughes. Berkeley: University of California, 2001.
   Google Scholar
• Bulkeley, William M. “Biogen’s Gilbert Resigns Top Posts, Acting Chief Picked.” Wall Street Journal (December 18, 1984): 1.
   Google Scholar
• Bush, Vannevar. Science: The Endless Frontier. Washington, DC: United States Government Printing Office, 1945.
   Google Scholar
• Cambrosio, Alberto, and Peter Keating. Exquisite Specificity: The Monoclonal Antibody Revolution. Oxford: Oxford University Press, 1995.
   Google Scholar
• Cape, Ronald. “Biotech Pioneer and Founder of Cetus.” Oral history conducted by Sally Smith Hughes. Berkeley: University of California, 2006.
   Google Scholar
• Carlson, Bernard W. “Academic Entrepreneurship and Engineering Education: Dugald C. Jackson and the MIT-GE Cooperative Engineering Course, 1907–1932.” Technology and Culture 29 (1988): 356–367.
   Web of Science ®Google Scholar
• de Chadarevian, Soraya. Designs for Life: Molecular Biology after World War II. Cambridge: Cambridge University Press, 2002.
   Google Scholar
• de Chadarevian, Soraya. “Using Interviews to Write the History of Science.” In The Historiography of Contemporary Science and Technology, edited by Thomas Söderqvist, 51–70. Amsterdam: Harwood Academic Publishers, 1997.
   Google Scholar
• Cohen, Stanley N. “DNA Cloning: A Personal View after Forty Years.” Proceedings of National Academy of Sciences 110 (2013): 15521–15529.10.1073/pnas.1313397110
   PubMed Web of Science ®Google Scholar
• Cohen, Stanley N. “The Manipulation of Genes.” Scientific American 233 (July 1975): 24–33.10.1038/scientificamerican0775-24
   Web of Science ®Google Scholar
• Cohen, Stanley N. “Science, Biotechnology, and Recombinant DNA: A Personal History.” Oral history conducted by Sally Smith Hughes. Berkeley: University of California, 2009.
   Google Scholar
• Davies, Julian. “Gathering No Moss.” Annual Review of Microbiology 57 (2003): 1–27.10.1146/annurev.micro.57.030502.090949
   PubMed Web of Science ®Google Scholar
• Delbrück, Max. “A Physicist’s Renewed Look at Biology – Twenty Years Later.” Science 168 (June 12, 1970): 1312–1315.10.1126/science.168.3937.1312
   PubMed Web of Science ®Google Scholar
• Delbrück, Max. Oral History Conducted by Carolyn Harding. Pasadena, CA: California Institute of Technology Archives Oral History Project, 1978.
   Google Scholar
• Demain, Arnold L. “History of Industrial Biotechnology.” In Industrial Biotechnology: Sustainable Growth and Economic Success, edited by Wim Soetaert and Erick J. Vandamme, 17–77. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA, 2010.10.1002/9783527630233
   Google Scholar
• Etzkowitz, Henry. “Entrepreneurial Science in the Academy: A Case of the Transformation of Norms.” Social Problems 36 (1989): 14–29.10.2307/800547
   Web of Science ®Google Scholar
• Etzkowitz, Henry. MIT and the Rise of Entrepreneurial Science. London: Routledge, 2002.10.4324/9780203216675
   Google Scholar
• Etzkowitz, Henry. “Research Groups as ‘Quasi-Firms’: The Invention of the Entrepreneurial University.” Research Policy 32 (2003): 109–121.10.1016/S0048-7333(02)00009-4
   Web of Science ®Google Scholar
• Etzkowitz, Henry. The Triple Helix: University-Industry-Government Innovation in Action. New York: Routledge, 2008.10.4324/9780203929605
   Google Scholar
• Fisher, Lawrence M. “The Rocky Road from Startup to Big-Time Player: Biogen’s Triumph against the Odds.” Strategy+Business (July 1, 1997): 55–63.
   Google Scholar
• Fishlock, David. “Biogen Attracts Staff with and Atmosphere of Freedom.” Globe and Mail (May 4, 1984): 1.
   Google Scholar
• Gaudillière, Jean-Paul. “Professional or Industrial Order? Patents, Biological Drugs, and Pharmaceutical Capitalism in Early Twentieth Century Germany.” History and Technology 24 (2008): 107–133.10.1080/07341510701810922
   Web of Science ®Google Scholar
• Geiger, Roger L. To Advance Knowledge: The Growth of American Research Universities. New York: Oxford University Press, 1986.
   Google Scholar
• Geison, Gerald L. The Private Science of Louis Pasteur. Princeton, NJ: Princeton University Press, 1995.
   Google Scholar
• Gilbert, Walter. “Protein Synthesis.” US Patent 4411994A, filed June 8, 1978.
   Google Scholar
• Ginzberg, Eli, and Anna B. Dutka. The Financing of Biomedical Research. Baltimore, MD: Johns Hopkins University Press, 1989.
   Google Scholar
• Gradmann, Christoph. “Money and Microbes: Robert Koch, Tuberculin, and the Foundation of the Institute for Infectious Diseases in Berlin in 1891.” History and Philosophy of the Life Sciences 22 (2000): 59–79.
   PubMed Web of Science ®Google Scholar
• Grant, Charley. “What Can Stop the World’s Best-Selling Drug?” Wall Street Journal (April 28, 2017): 1.
   Google Scholar
• Gros, Francois, Howard Hiatt, Walter Gilbert, Chuck G. Kurland, R. W. Risebrough, and James D. Watson. “Unstable Ribonucleic Acid Revealed by Pulse-Labeled Escherichia Coli.” Nature 190 (1961): 581–585.10.1038/190581a0
   PubMed Web of Science ®Google Scholar
• Guagnini, Anna. “Ivory Towers? The Commercial Activity of British Professors of Engineering and Physics, 1880–1914.” History and Technology 33 (2017): 70–108.
   Web of Science ®Google Scholar
• Hall, Stephen S. “Biologist in the Boardroom.” Science 85, no. 6 (January/February 1985): 42–50.
   Google Scholar
• Hall, Stephen. Invisible Frontiers: The Race to Synthesize a Human Gene. New York: Atlantic Monthly Press, 1987.
   Google Scholar
• “Harvard, Biogen in Patent Deal.” 1983. The New York Times, November 29: p. D5.
   Google Scholar
• “Harvard Considers Commercial Role in DNA Research.” 1980. The New York Times, October 27: p. A1.
   Google Scholar
• Harwood, Jonathan. “Universities.” In The Cambridge History of Science, Volume 6: Modern Life and Earth Sciences, edited by Peter J. Bowler and John V. Pickstone, 90–107. Cambridge: Cambridge University Press, 2009.10.1017/CHOL9780521572019
   Google Scholar
• Hilts, Philip J. “The Gold Rush of Companies in Biotechnology is Waning.” Washington Post (November 3, 1981): A1.
   PubMedGoogle Scholar
• Hoddeson, Lillian. “The Conflict of Memories and Documents: Pragmatics and Dilemmas of Oral History.” In The Historiography of Contemporary Science, Technology, and Medicine: Writing Recent Science, edited by Ronald E. Doel and Thomas Söderqvist, 187–200. New York: Routledge, 2006.
   Google Scholar
• Hofschneider, Peter-Hans, and Kenneth Murray. “Combining Science and Business: From Recombinant DNA to Vaccines against Hepatitis B Virus.” In Recombinant Protein Drugs, edited by P. Buckel, 43–64. Basel: Birkhäuser, 2001.10.1007/978-3-0348-8346-7
   Google Scholar
• Hughes, Sally Smith. Genentech: The Beginnings of Biotech. Chicago, IL: University of Chicago Press, 2011.10.7208/chicago/9780226359205.001.0001
   Google Scholar
• Hughes, Sally Smith. “Making Dollars out of DNA: The First Major Patent in Biotechnology and the Commercialization of Molecular Biology, 1974–1980.” Isis (2001): 541–575.10.1086/385281
   PubMed Web of Science ®Google Scholar
• Jones, Mark. 2013. “The Invention of Recombinant DNA Technology.” LSF Magazine, Summer: pp. 48–75.
   Google Scholar
• Judson, Horace Freeland. The Eighth Day of Creation: Makers of the Revolution in Biology. New York: Simon & Schuster, 1979.
   Google Scholar
• Katzir, Shaul. “Technological Entrepreneurship from Patenting to Commercializing: A Survey of Late Nineteenth and Early Twentieth Century Physics Lecturers.” History and Technology 33(2017): 109–125.
   Web of Science ®Google Scholar
• Kay, Lily E. The Molecular Vision of Life: Caltech, the Rockefeller Foundation, and the Rise of the New Biology. New York: Oxford University Press, 1993.
   Google Scholar
• Kenney, Martin. Biotechnology: The University-Industrial Complex. New Haven, CT: Yale University Press, 1988.
   Google Scholar
• Kenney, Martin, ed. Understanding Silicon Valley: The Anatomy of an Entrepreneurial Region. Stanford, CA: Stanford University Press, 2000.
   Google Scholar
• Kimmelman, Barbara A. “The American Breeders’ Association: Genetics and Eugenics in an Agricultural Context 1903–13.” Social Studies of Science 13 (1983): 163–204.10.1177/030631283013002001
   PubMed Web of Science ®Google Scholar
• Knight, Michael. 1980. “Harvard Rules out Role for Now in Genetic Engineering Company.” The New York Times, November 18: p. A1.
   Google Scholar
• Kohler, Robert E. From Medicinal Chemistry to Biochemistry: The Making of a Biomedical Discipline. Cambridge: Cambridge University Press, 1982.10.1017/CBO9780511897313
   Google Scholar
• Kohler, Robert E. Partners in Science: Foundations and Natural Scientists, 1900–1945. Chicago, IL: University of Chicago Press, 1991.
   Google Scholar
• Kohler, Robert E. Lords of the Fly: Drosophila Genetics and the Experimental Life. Chicago, IL: University of Chicago Press, 1994.
   Google Scholar
• König, Wolfgang. “Engineering Professors as Entrepreneurs: The Case of Franz Reuleaux (1829–1905) and Alois Riedler (1850–1936).” History and Technology 33 (2017): 53–69.
   Web of Science ®Google Scholar
• Krimsky, Sheldon, James G. Ennis, and Robert Weissman. “Academic-Corporate Ties in Biotechnology: A Quantitative Study.” Science, Technology & Human Values 16 (1991): 275–287.10.1177/016224399101600301
   PubMed Web of Science ®Google Scholar
• Lécuyer, Christophe. Making Silicon Valley: Innovation and the Growth of High Tech, 1930–1970. Cambridge, MA: MIT Press, 2007.
   Google Scholar
• Linton, Derek S. Emil Von Behring: Infectious Disease, Immunology, and Serum Therapy. Philadelphia, PA: American Philosophical Society, 2005.
   Google Scholar
• Mach, Bernard. “The ‘Paradox’ of Today’s Biotechnology Companies.” Technology by Bilan (October 2011): 8.
   Google Scholar
• MacLeod, Christine. “Reluctant Entrepreneurs: Patents and State Patronage in New Technosciences, circa 1879–1930.” Isis 103 (2012): 328–339.10.1086/666359
   PubMed Web of Science ®Google Scholar
• Maxam, Allan M., and Walter Gilbert. “A New Method for DNA Sequencing.” Proceedings of the National Academy of Sciences 74 (1977): 560–564.10.1073/pnas.74.2.560
   PubMed Web of Science ®Google Scholar
• Mercelis, Joris. “Commercializing Academic Knowledge and Reputation in the Late Nineteenth and Early Twentieth Centuries: Photography and Beyond.” History and Technology 33(2017): 23–52.
   Web of Science ®Google Scholar
• Mirowski, Philip. Science-Mart: Privatizing American Science. Cambridge, MA: Harvard University Press, 2011.10.4159/harvard.9780674061132
   Google Scholar
• Mirowski, Philip and Esther-Mirjam Sent. “The Commercialization of Science and the Response of STS.” In The Handbook of Science and Technology Studies, 3rd ed., edited by Edward J. Hackett, Olga Amsterdamska, Michael Lynch, and Judy Wajcman, 635–689. Cambridge, MA: MIT Press, 2008.
   Google Scholar
• Morange, Michael. A History of Molecular Biology. Translated by Matthew Cobb. Cambridge, MA: Harvard University Press, 1998.
   Google Scholar
• Moses, Vivian, and Ronald E. Cape, eds. “The Science and the Business: An Introduction.” In Biotechnology: The Science and the Business, edited by Vivian Moses and Ronald E. Cape, 1–10. Amsterdam: Harwood Academic Publishers, 1991.
   Google Scholar
• Olby, R. C. The Path to the Double Helix. New York: Macmillan, 1974.
   Google Scholar
• Palladino, Paolo. “Between Craft and Science: Plant Breeding, Mendelian Genetics, and Universities, British 1900–1920.” Technology & Culture 34 (1993): 300–323.10.2307/3106538
   Web of Science ®Google Scholar
• Podolsky, Scott H. “Metchnikoff and the Microbiome.” The Lancet 380 (November 24,2012): 1810–1811.10.1016/S0140-6736(12)62018-2
   PubMed Web of Science ®Google Scholar
• Porter, Dorothy, ed. The History of Public Health and the Modern State. Amsterdam: Editions Rodopi B.V., 1994.
   Google Scholar
• Quirke, Viviane, and Jean-Paul Gaudillière. “The Era of Biomedicine: Science, Medicine, and Public Health in Britain and France after the Second World War.” Medical History 52 (2008): 441–452.10.1017/S002572730000017X
   PubMed Web of Science ®Google Scholar
• Rasmussen, Nicolas. Gene Jockeys: Life Sciences and the Making of the First Biotech Drugs. Baltimore, MD: Johns Hopkins University Press, 2014.
   Google Scholar
• Rasmussen, Nicolas. “The Forgotten Promise of Thiamin: Merck, Caltech Biologists, and Plant Hormones in a 1930s Biotechnology Project.” Journal of the History of Biology 32 (1999): 245–261.10.1023/A:1004635500408
   Web of Science ®Google Scholar
• Reimers, Niels. “Tiger by the Tail.” ChemTech (August 1987): 464–471.
   Google Scholar
• Reiner, Martha Louise. The Transformation of Venture Capital: A History of Venture Capital Organizations in the United States. Berkeley: University of California, 1989.
   Google Scholar
• Rheinberger, Hans-Jörg. “What Happened to Molecular Biology?” B.I.F. Futura 22 (2007): 214–217.
   Google Scholar
• Rosegrant, Susan, and David R. Lampe. Route 128: Lessons from Boston’s High-Tech Community. New York: Basic Books, 1992.
   Google Scholar
• Sampat, Bhaven N. “Patenting and US Academic Research in the 20th Century: The World before and after Bayh-Dole.” Research Policy 35 (2006): 772–789.10.1016/j.respol.2006.04.009
   Web of Science ®Google Scholar
• Schaefer, Chris H., and Raymond H. Schaefer. Biotech Visionary. Mansfield, CT: Java, 2012.
   Google Scholar
• Schrödinger, Erwin. What is Life? The Physical Aspect of the Living Cell. Cambridge: Cambridge University Press, 1944.
   Google Scholar
• Shapin, Steven. “The Ivory Tower: The History of a Figure of Speech and Its Culture Uses.” British Journal of the History of Science 45 (2012): 1–27.10.1017/S0007087412000118
   Web of Science ®Google Scholar
• Shapin, Steven. The Scientific Life: A Moral History of a Late Modern Vocation. Chicago, IL: University of Chicago Press, 2008.10.7208/chicago/9780226750170.001.0001
   Google Scholar
• Slaughter, Sheila, and Larry L. Leslie. Academic Capitalism: Politics, Policies, and the Entrepreneurial University. Baltimore, MD: The Johns Hopkins University Press, 1997.
   Google Scholar
• Starr, Paul. The Social Transformation of American Medicine. New York: Basic Books, 1982.
   Google Scholar
• Strasser, Bruno J. “Institutionalizing Molecular Biology in Postwar Europe: A Comparative Study.” Studies in History and Philosophy of Biological and Biomedical Sciences 33 (2002): 515–546.10.1016/S1369-8486(02)00016-X
   Google Scholar
• Swanson, Robert A. “Co-founder, CEO, and Chairman of Genentech Inc, 1976–1996.” Oral history conducted by Sally Smith Hughes. Berkeley: University of California, 2001.
   Google Scholar
• Weaver, Warren. “Molecular Biology: The Origin of the Term.” Science 170 (1970): 581–582.10.1126/science.170.3958.581-a
   PubMed Web of Science ®Google Scholar
• Weiner, Charles. “Patenting and Academic Research: Historical Case Studies.” Science, Technology, & Human Values 12 (1987): 50–62.
   Web of Science ®Google Scholar
• Weissmann, Charles. “The End of the Road.” Prion 6 (2012): 1–8.
   PubMed Web of Science ®Google Scholar
• Weissmann, Charles. “The Cloning of Interferon and Other Mistakes.” In Interferon 3, edited by I. Gresser, 101–134. New York: Academic Press, 1981.
   Google Scholar
• Wright, Susan. “Recombinant DNA Technology and Its Social Transformation, 1972–1982.” Osiris 2 (1986): 303–360.10.1086/368659
   PubMed Web of Science ®Google Scholar
• Yi, Doogab. The Recombinant University: Genetic Engineering and the Emergence of Stanford Biotechnology. Chicago, IL: University of Chicago Press, 2015.10.7208/chicago/9780226216119.001.0001
   Google Scholar
• Zucker, Lynne G., and Michael R. Darby. “Star Scientists and Institutional Transformation: Patterns of Invention and Innovation in the Formation of the Biotechnology Industry.” Proceedings of the National Academy of Sciences 93 (1996): 12709–12716.10.1073/pnas.93.23.12709
   PubMed Web of Science ®Google Scholar